BMS-605541


CAS No. : 639858-32-5

639858-32-5
Price and Availability of CAS No. : 639858-32-5
Size Price Stock
5mg $95 In-stock
10mg $150 In-stock
25mg $320 In-stock
50mg $520 In-stock
100mg $830 In-stock
200 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-120640
M.Wt: 401.43
Formula: C19H17F2N5OS
Purity: >98 %
Solubility: DMSO : 33.33 mg/mL (ultrasonic;warming;heat to 60°C)
Introduction of 639858-32-5 :

BMS-605541 is a selective and orally active inhibitor of VEGFR-2 kinase with an IC50 value of 23 nM and Ki value of 49 nM. BMS-605541 inhibits the activity of Flk-1, VEGFR-1 and PDGFR-β with IC50 values of 40 nM, 400 nM and 200 nM, respectively. BMS-605541 can be used for cancer research[1]. In Vitro:BMS-605541 (Compound 14) inhibits the growth of HUVECs through VEGF with an IC50 value of 25 nM[1].
In Vivo:BMS-605541 (12.5-180 mg/kg; once a day or twice a day for 14 days) has anti-tumor activity in thymic mice subcutaneously implanted with L2987 and HCT-116 xenografts[1].
Pharmacokinetic (PK) parameters of BMS-605541[1]
Species Administration manner Dose (mg/kg) Cmax (µM) Tmax (h) AUC (µM•h) T1/2 (h) MRT (h) Cl (mL/min•kg) Vss (L/kg) Fpo (%)
Mouse Oral gavage 90 148 0.5 649 (0-24 h) 1.7 3.4 100
Mouse Intravenous injection 10 11.8 1.7 100
Rat Oral gavage 50 44.0 2.0 202 2.2 3.5 100
Rat Intravenous injection 10 13.6 1.1 100
Cyno Oral gavage 5 8.0 0.75 28.5 7.1 7.9 52
Cyno Intravenous injection 1 3.9 1.6 52

Your information is safe with us.